Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRTXOTCMKTS:CBAIOTCMKTS:MITIOTCMKTS:PFHO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRTXBiorestorative Therapies$1.58-0.4%$1.72$1.21▼$2.55$11.93M75.28142,735 shs43,517 shsCBAICBA Florida$0.01+1.3%$0.01$0.01▼$0.01$9.91MN/A2.73 million shs19.77 million shsMITIMitesco$0.34-3.5%$0.34$0.00▼$1.00$3.90M1.675,160 shs5,128 shsPFHOPacific Health Care Organization$0.80$0.82$0.65▼$0.99$10.24M-0.0321,061 shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRTXBiorestorative Therapies-0.38%-5.15%-11.01%-8.17%-15.29%CBAICBA Florida0.00%0.00%0.00%0.00%0.00%MITIMitesco-3.49%-14.39%+23.83%-39.66%+16.52%PFHOPacific Health Care Organization0.00%0.00%-4.76%+11.11%-9.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRTXBiorestorative Therapies2.7865 of 5 stars3.53.00.00.00.63.30.6CBAICBA FloridaN/AN/AN/AN/AN/AN/AN/AN/AMITIMitescoN/AN/AN/AN/AN/AN/AN/AN/APFHOPacific Health Care OrganizationN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRTXBiorestorative Therapies 3.00Buy$18.001,036.36% UpsideCBAICBA Florida 0.00N/AN/AN/AMITIMitesco 0.00N/AN/AN/APFHOPacific Health Care Organization 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRTXBiorestorative Therapies$400K29.70N/AN/A$1.23 per share1.29CBAICBA FloridaN/AN/AN/AN/AN/AN/AMITIMitesco$40K94.25N/AN/A($2.70) per share-0.13PFHOPacific Health Care Organization$6.07M1.69$0.07 per share11.15$0.91 per share0.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRTXBiorestorative Therapies-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)CBAICBA Florida-$40KN/A0.00∞N/AN/AN/AN/AN/AMITIMitesco-$2.51MN/A0.00∞N/A1,456.66%N/A-1,202.21%N/APFHOPacific Health Care Organization$880K$0.0711.43∞N/A15.18%8.47%7.97%8/5/2025 (Estimated)Latest MITI, BRTX, PFHO, and CBAI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025MITIMitescoN/A-$0.08N/A-$0.08N/A$0.02 million5/14/2025Q1 2025BRTXBiorestorative Therapies-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million5/2/2025Q1 2025PFHOPacific Health Care OrganizationN/A$0.02N/A$0.02N/A$1.82 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRTXBiorestorative TherapiesN/AN/AN/AN/AN/ACBAICBA FloridaN/AN/AN/AN/AN/AMITIMitescoN/AN/AN/AN/AN/APFHOPacific Health Care OrganizationN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRTXBiorestorative TherapiesN/A2.242.24CBAICBA FloridaN/AN/AN/AMITIMitescoN/AN/AN/APFHOPacific Health Care OrganizationN/A18.5518.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRTXBiorestorative Therapies69.38%CBAICBA FloridaN/AMITIMitesco0.01%PFHOPacific Health Care OrganizationN/AInsider OwnershipCompanyInsider OwnershipBRTXBiorestorative Therapies25.50%CBAICBA Florida30.00%MITIMitesco4.90%PFHOPacific Health Care Organization61.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRTXBiorestorative Therapies77.50 million5.59 millionNot OptionableCBAICBA Florida21.27 billion890.45 millionNot OptionableMITIMitesco3011.16 million10.61 millionNot OptionablePFHOPacific Health Care Organization3012.80 million4.92 millionNot OptionableMITI, BRTX, PFHO, and CBAI HeadlinesRecent News About These CompaniesChile joins PAHO-led Alliance to strengthen primary health care systemsMay 26, 2025 | msn.comPacific Health Care Organization, Inc. Reports its First Quarter 2025 Financial ResultsMay 2, 2025 | globenewswire.comPAHO insists on the importance of universal access to careApril 20, 2025 | en.mercopress.comEPAHO warns of increase in yellow fever casesMarch 27, 2025 | cidrap.umn.eduCPAHO warns of NCDs spreading in the regionMarch 27, 2025 | en.mercopress.comEPacific Health Care Organization, Inc. Reports its 2024 Year-End Financial ResultsMarch 19, 2025 | globenewswire.comPAHO is Latin America's Centre for Disease Control and PreventionMarch 1, 2025 | thelancet.comTDespite WHO exit plan, US still in Americas health agencyFebruary 27, 2025 | reuters.comIn PAHO-backed access initiative, Argentina's Sinergium Biotech to locally produce Pfizer's Prevnar 20January 16, 2025 | fiercepharma.comFASPPH Applauds Milestone Collaboration Between PAHO and WHO AcademyJanuary 8, 2025 | aspph.orgAHawaii Pacific Health's four-step approach to training leadersNovember 9, 2024 | bizjournals.comWaipahu High School offers hands-on health care trainingNovember 8, 2024 | bizjournals.comPacific Health Care Organization, Inc. Reports its Third Quarter 2024 ResultsNovember 5, 2024 | globenewswire.comProvidence to outsource home health, hospice services to private equity-backed CompassusOctober 25, 2024 | oregonlive.comOHow Asian Americans are filling the gaps in care for their elderly parentsOctober 22, 2024 | pbs.orgPDignity Health hones in on creating large cardiovascular groupOctober 19, 2024 | pacbiztimes.comPMetro Pacific Health, mWell ink referral partnershipOctober 18, 2024 | bworldonline.comBCreating Equitable Cancer Care for Americans of Asian and Pacific Islander HeritageOctober 16, 2024 | ajmc.comADLR Group Appoints Healthcare Design Project Leader for Pacific NorthwestOctober 12, 2024 | healthcaredesignmagazine.comHPentagon announces pilot program to improve health care access for civilians in JapanOctober 7, 2024 | stripes.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMITI, BRTX, PFHO, and CBAI Company DescriptionsBiorestorative Therapies NASDAQ:BRTX$1.58 -0.01 (-0.38%) As of 07/3/2025 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.CBA Florida OTCMKTS:CBAI$0.0078 +0.00 (+1.30%) As of 06/30/2020CBA Florida, Inc. does not have significant operations. Previously, the company provided private cord blood and cord tissue stem cell services. The company was formerly known as Cord Blood America, Inc. and changed its name to CBA Florida, Inc. in May 2018. CBA Florida, Inc. is based in Las Vegas, Nevada.Mitesco OTCMKTS:MITI$0.34 -0.01 (-3.49%) As of 07/3/2025 11:39 AM EasternMitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.Pacific Health Care Organization OTCMKTS:PFHO$0.80 0.00 (0.00%) As of 07/1/2025Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
